Advertisement

Topics

Latest "Global Dairy Platform" News Stories

21:54 EDT 21st September 2018 | BioPortfolio

Here are the most relevant search results for "Global Dairy Platform" found in our extensive news archives from over 250 global news sources.

More Information about Global Dairy Platform on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global Dairy Platform for you to read. Along with our medical data and news we also list Global Dairy Platform Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global Dairy Platform Companies for you to search.

Showing "Global Dairy Platform" News Articles 1–25 of 19,000+

Friday 21st September 2018

Rosen Law Firm Reminds Nielsen Holdings plc Investors of Important Deadline in Class Action

NEW YORK, Sept. 21, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Nielsen Holdings plc Read more...


United Nations HeForShe IMPACT Summit to launch groundbreaking global solutions for gender ...

NEW YORK, Sept. 21, 2018 /PRNewswire/ -- On September 26th, the United Nations HeForShe movement is convening world leaders, global CEOs, activists and celebrities to Read more...

Magnolia Medical secures technology contract from Vizient

The contract resulted from the Steripath Gen 2 Initial Specimen Diversion Device technology platform being recommended by hospital experts in this category who serve on one of Vizient’s member-led The post Magnolia Medical secures technology contract from Vizient appeared first on Compelo Medical Devices.


Mologen (MGN) - Global lefitolimod partnership close to completion

Edison Investment Research - Pharmaceutical & healthcare - Mologen: Mologen announced that it has signed term sheets for a global partnership with Oncologie for its lead asset, lefitolimod. The deal is expected to complete in Q119, and in the near term Mologen expects to receive €23m from the agreement in a combination of R&D funding, cash payment and bond issues. Sensitivity remains arou...

Akili licenses UCSF's cognitive optimization video game platform to create CNS digital treatments

Digital medicine company Akili Interactive Labs Inc. secured an exclusive license from the Regents of the University of Calif...

Global Cord Blood Corporation to Hold Annual General Meeting of Shareholders in Hong Kong on December 5, 2018

HONG KONG, Sept. 21, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2018 annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of...

Ichor's Auctus Biologics Closes Quick $1.5MM

Auctus Biologics, Inc., a new portfolio company of Ichor Therapeutics, Inc., announced today the closure of $1.5MM in seed funding. The company will develop RPtag, a hyper-stable antibody mimetic scaffold published earlier th

Wolters Kluwer’s Digital Medical Education Resource Awarded First Prize at the British Medical Association Book Awards

12 Leading Lippincott Texts Also Recognized at the 2018 BMA Awards Wolters Kluwer, Health announced today its leading digital anatomy resource, Grant’s Dissection Videos, was awarded first-prize in the digital/online resources category, and received highly commended recognitions for 12 Lippincott® medical texts in their categories. The annual...

New micro-platform improves understanding of cancer cells

A new low-cost, cell culture platform technique may provide insight for more effective cancer treatment, according to the researchers who developed it... The post

Shire Receives Approval of FIRAZYR (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan

Shire (LSE:SHP,NASDAQ:SHPG) the leading global biotechnology company focused on rare diseases, announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has granted manufacturing and marketing authorisation for FIRAZYR (icatibant injection), for the acute treatment of hereditary angioedema (HAE) attacks in adult patients with HAE. As quoted in the press release: HAE is a … C...

Report: Deception in clinical trials ‘squanders precious research resources’

Deception among clinical research participants is prevalent and a global issue, say researchers, with self-reported adherence found to be largely inaccurate.

We know early science can lead to breakthroughs for global health. That is why we have committed an additional £5m to support the Tres Cantos Open Lab Foundation, a GSK-founded independent charity

We know early science can lead to breakthroughs for global health. That is why we have committed an additional £5m to support the Tres Cantos Open Lab Foundation, a GSK-founded independent charity

DATA: Results Recap: Terumo PulseCath Shows Promise In High-Risk PCI; Reapplix' LeucoPatch Promotes Ulcer-Healing

Results Recap is Medtech Insight's exclusive summary of clinical trial results that have been announced or published in the past...  &#

Medtronic to Acquire Mazor Robotics in $1.64 Billion Deal

DUBLIN and CAESAREA, Israel – September 20, 2018 – Medtronic plc (NYSE:MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ), a pioneer in the field of robotic guidance systems, today announced the companies have entered into a definitive merger agreement under which Medtronic will acquire all outstanding ordinary shares of Mazor for $58.50 …...

TriSalus Life Sciences Strengthens Commercial and Operational Leadership, Names Daniel Estay as Its Chief Business Officer

Leadership Appointment Supports Strategic Shift to Build Oncology Drug Delivery Company TriSalus Life Sciences announced the appointment of Daniel Estay as its chief business officer, reporting to the company’s chief executive officer, Mary Szela. The appointment deepens the leadership capabilities of the company, supporting its strategic shift to be...

Enigma Biomedical and Invicro Sign a Memorandum of Understanding to Co-Develop Synaptic Density Biomarker Imaging

Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to cooperate in the development of Synaptic Density Biomarker Imaging (“SDI”). SDI promises to provide an important new tool in understanding neurodegen...

Novartis receives positive CHMP opinion for Gilenya® for the treatment of children and adolescents with MS, marking a major medical advance for young MS patients in Europe

Novartis International AG / Novartis receives positive CHMP opinion for Gilenya® for the treatment of children and adolescents with MS, marking a major medical advance for young MS patients in Europe . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Children and adolescents with multiple sclerosi...

Kate Farms Applauds Jerry Brown Signing of SB 1138, a Law Requiring California Institutions to Offer Plant-Based Meals

Kate Farms Plant-based Formulas Meet These New Legal Requirements for Institutional Use, Including Hospitals Kate Farms, Inc., a medical nutrition company leading the next generation of oral and tube feeding formulas commends Jerry Brown on signing SB 1138 into law, ensuring that patients in hospital facilities in California have access to whole...

IONpath Shares Comprehensive Studies of Enumeration of Immune Cells in Solid Tumors in Educational Webinar

Through this webinar, which LabRoots will host October 2, attendees will gain a better understanding of how MIBI technology enables simultaneous imaging of 40+ markers in FFPE tissue to analyze the tumor microenvironment. YORBA LINDA, Calif. (PRWEB) September 21, 2018 Understanding the role of distinct cellular phenotypes in tissue function, development, and pathogenesis requires tools that can r...

b-ONE Ortho Receives U.S. FDA 510(k) Clearance for Total Hip System

b-ONE Ortho Corp., an emerging orthopedic technology company dedicated to the development of innovative healthcare solutions, today announced it has received 510(k) clearance for its first device, the b-ONETM Total Hip System, from the U.S. Food and Drug Administration (FDA). The b-ONETM Total Hip System is a cementless total hip system with advan...

Accenture Introduces Ella and Ethan, AI Bots to Improve a Patient’s Health and Care Using the Accenture Intelligent Patient Platform

Accenture (NYSE: ACN) has enhanced the Accenture Intelligent Patient Platform with the addition of Ella and Ethan, two interactive virtual-assistant bots that use artificial intelligence (AI) to constantly learn and make intelligent recommendations for interactions between life sciences companies, patients, health care providers (HCPs) and caregivers. Desi...

Guided Therapeutics Announces New Agreement to Promote Sales and Marketing in Russia and Eastern Europe

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced it has signed a letter of intent with its Russian and Eastern European Sales and Marketing partner, Newmars Group Kft., to accelerate marketing and sales of the LuViva Advanced Cervical Scan in those terr...

Cedar Unveils Next Evolution of Patient Payment Platform to Optimize Revenue Cycle

Cedar, a patient payment and engagement platform, announced the next evolution of its flagship solution, Cedar Pay. The enhancements now allow providers to offer a truly unified patient billing experience and simple checkout options. Healthcare executives still struggle to help patients understand and pay healthcare bills, with 50 percent of provider executives reporting the need ... Read More

Canon Medical System Corporation partners with ACT Genomics for Precision Cancer Medicine Service in Japan

TAIPEI, Taiwan, Sept. 21, 2018 /PRNewswire/ -- Canon Medical System Corporation (Canon Medical) completed the acquisition of the majority shares of ACTmed - a joint venture company established with ACT Genomics (ACTG), a Taiwanese molecular diagnostic company. ACTG will transfer its clinical NGS technology to ACTmed, making ACTG the first Taiwanese biotech company to transfer technology to a major...

Climate Change Modifies the Composition of Reefs

NewsThe gorgonians are replacing scleractinian corals that are disappearing from marine ecosystems due to human impact and global climate change. Contribute


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks